10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
13.14
-0.43 (-3.17%)
Aug 14, 2025, 12:02 PM - Market open

10x Genomics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
397.71344.07359.28219.75587.45663.6
Upgrade
Short-Term Investments
49.5549.3429.41210.24--
Upgrade
Cash & Short-Term Investments
447.26393.4388.7429.98587.45663.6
Upgrade
Cash Growth
17.67%1.21%-9.60%-26.80%-11.48%56.45%
Upgrade
Receivables
119.0787.86114.83104.2185.2551.21
Upgrade
Inventory
68.9783.1173.7181.6359.9729.96
Upgrade
Prepaid Expenses
20.3720.0218.7916.5813.913.03
Upgrade
Restricted Cash
---2.631.0316.57
Upgrade
Total Current Assets
655.66584.39596.02635.04747.59774.37
Upgrade
Property, Plant & Equipment
302.41309.94344.93359.21230.41119.82
Upgrade
Goodwill
4.514.514.514.514.51-
Upgrade
Other Intangible Assets
14.7115.6716.6222.8625.422.35
Upgrade
Other Long-Term Assets
2.674.133.067.3710.9212.8
Upgrade
Total Assets
979.97918.64965.141,0291,019929.34
Upgrade
Accounts Payable
15.9412.9115.7421.617.354.71
Upgrade
Accrued Expenses
38.9252.0745.9851.953.2735.09
Upgrade
Current Portion of Leases
9.679.2911.529.045.135.94
Upgrade
Current Income Taxes Payable
4.974.945.054.084.628.65
Upgrade
Current Unearned Revenue
21.4520.6613.157.875.344.47
Upgrade
Other Current Liabilities
21.2817.7735.7336.4824.6459.27
Upgrade
Total Current Liabilities
112.22117.63127.16130.96110.36118.13
Upgrade
Long-Term Leases
77.0873.3383.8586.1476.8557.04
Upgrade
Long-Term Unearned Revenue
11.2712.518.813.17--
Upgrade
Other Long-Term Liabilities
6.135.034.282.9814.0515.1
Upgrade
Total Liabilities
206.69208.5224.1223.24201.26190.27
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
2,2402,1782,0261,8391,6811,544
Upgrade
Retained Earnings
-1,467-1,467-1,284-1,029-863.32-805.1
Upgrade
Comprehensive Income & Other
0.22-0.49-0.43-4.340.02-0.05
Upgrade
Total Common Equity
773.28710.13741.04805.74817.57739.07
Upgrade
Shareholders' Equity
773.28710.13741.04805.74817.57739.07
Upgrade
Total Liabilities & Equity
979.97918.64965.141,0291,019929.34
Upgrade
Total Debt
86.7482.6195.3795.1881.9862.98
Upgrade
Net Cash (Debt)
360.52310.79293.33334.81505.47600.63
Upgrade
Net Cash Growth
24.05%5.95%-12.39%-33.76%-15.84%52.27%
Upgrade
Net Cash Per Share
2.952.582.502.944.585.94
Upgrade
Filing Date Shares Outstanding
124.49122.3119.17115.36112.84108.75
Upgrade
Total Common Shares Outstanding
124.44122.29119.1115.2112.51108.49
Upgrade
Working Capital
543.44466.75468.86504.08637.23656.24
Upgrade
Book Value Per Share
6.215.816.226.997.276.81
Upgrade
Tangible Book Value
754.05689.95719.92778.37787.66716.72
Upgrade
Tangible Book Value Per Share
6.065.646.046.767.006.61
Upgrade
Land
36.7736.7736.7736.7836.1-
Upgrade
Buildings
147.49147.09146.04---
Upgrade
Machinery
101.8797.0496.676.8762.6941.68
Upgrade
Construction In Progress
2.745.157.2515352.1919.59
Upgrade
Leasehold Improvements
90.6389.5796.4191.5267.5342.07
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q